MDxHealth (MDXH) Asset Writedowns and Impairment (2024 - 2025)

MDxHealth's (MDXH) quarterly Asset Writedowns and Impairment came in at $367000.0 in Q3 2025, down 30.49% quarter-over-quarter from $528000.0 in Q2 2025.

MDxHealth (MDXH) Asset Writedowns and Impairment (2024 - 2025) Analysis & Trends

MDxHealth has disclosed Asset Writedowns and Impairment across 2 years of filings, most recently posting $367000.0 for Q3 2025.

  • Asset Writedowns and Impairment for Q3 2025 came in at $367000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $4.0 million (changed N/A YoY), and the FY2025 annual result was $683000.0, changed N/A from the prior year.
  • Asset Writedowns and Impairment came in at $367000.0 for Q3 2025 at MDxHealth, down from $528000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.1 million in Q2 2024 to a low of $367000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Waters 30,010.71 Bn 30,010.25 Bn 1.11 Bn
2 Thermo Fisher Scientific 179.46 Bn 176.21 Bn 7.74 Bn
3 Danaher 130.33 Bn 124.64 Bn 3.59 Bn
4 Idexx Laboratories 44.44 Bn 44.24 Bn 722.74 Mn
5 Agilent Technologies 37.27 Bn 35.46 Bn 990.00 Mn
6 Iqvia Holdings 30.70 Bn 28.73 Bn 1.36 Bn
7 Natera 30.59 Bn 29.49 Bn 696.04 Mn
8 Illumina 24.86 Bn 23.71 Bn 721.00 Mn
9 Mettler Toledo International 23.06 Bn 23.00 Bn 555.82 Mn
10 MDxHealth 5,974.10 -43.15 Mn 16.61 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 367,000.00
Sep 30, 2025 367,000.00
Jun 30, 2025 528,000.00
Jun 30, 2025 528,000.00
Jun 30, 2024 3.13 Mn
Jun 30, 2024 3.13 Mn